Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease
NCT02094222
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
OTHER
Sponsor class
Conditions
Byler Disease
Interventions
DRUG:
RAVICTI
Sponsor
Robert Squires, Jr.